Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma

Abstract

Meningiomas are generally benign and in most cases surgery is curative. However, for high-grade histotypes or partially resected tumours, recurrence is fairly common. External beam radiation therapy (EBRT) is usually given in such cases but is not always effective. We assessed peptide receptor radionuclide therapy (PRRT) using 90Y-DOTATOC in a group of patients with meningioma recurring after standard treatments in all of whom somatostatin receptors were strongly expressed on meningioma cell surfaces. Twenty-nine patients with scintigraphically proven somatostatin subtype 2 receptor-positive meningiomas were enrolled: 14 had benign (grade I), 9 had atypical (grade II) and 6 had malignant (grade III) disease. Patients received intravenous 90Y-DOTATOC for 2–6 cycles for a cumulative dose in the range of 5–15 GBq. Clinical and neuroradiological evaluations were performed at baseline, during and after PRRT. The treatment was well tolerated in all patients. MRI 3 months after treatment completion showed disease stabilization in 19 of 29 patients (66%) and progressive disease in the remaining 10 (34%). Better results were obtained in patients with grade I meningioma than in those with grade II–III, with median time to progression (from beginning PRRT) of 61 months in the low-grade group and 13 months in the high-grade group. PRRT with 90Y-DOTATOC can interfere with the growth of meningiomas. The adjuvant role of this treatment, soon after surgery, especially in atypical and malignant histotypes, deserves further investigation.

DOI: 10.1007/s00259-009-1115-z

7 Figures and Tables

05001000200920102011201220132014201520162017
Citations per Year

1,333 Citations

Semantic Scholar estimates that this publication has 1,333 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Bartolomei2009PeptideRR, title={Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma}, author={Mirco Bartolomei and Lisa Bodei and Concetta de Cicco and Chiara Maria Grana and Marta Cremonesi and Edoardo Botteri and Silvia Melania Baio and Demetrio Aric{\`o} and Maddalena Sansovini and Giovanni Paganelli}, journal={European Journal of Nuclear Medicine and Molecular Imaging}, year={2009}, volume={36}, pages={1407-1416} }